From: Medical Device + Diagnostic Industry

FDA launched two major initiatives in 2016—cybersecurity requirements and a national system for real-world device monitoring.

Jim Dickinson

The last year of the Obama Administration will likely be remembered by FDA-watchers for two major agency initiatives affecting medical device regulation: cybersecurity requirements and CDRH’s establishment of a National Evaluation System for “real world” device monitoring, one of three strategic priorities for the 2016-2017 timeframe.

Each of these has been under congressional scrutiny, something that both the Trump Administration and the reinvigorated Republican majorities on Capitol Hill seem likely to continue.

Read Complete Article